Claims involving vascular port patents came to an uncommon end in the District of Delaware on Thursday, with a judge overturning a blanket jury verdict for the plaintiffs and siding with the defense on eligibility issues.

The eligibility of the claims made by CR Bard Inc. against AngioDynamics Inc. has been disputed for years, with a similar ruling made mid-trial reversed by the Federal Circuit and sent back to Delaware for a second trial before  U.S. District Senior Judge Joseph Bataillon of the District of Nebraska, who took over the case following the 2017 retirement of Judge Sue L. Robinson.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]